(Q24243734)

2

0 references

Rong Le Zhou

3

0 references

Jun Li

4

0 references

Guan Jian Liu

Cochrane Database of Systematic Reviews

5

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Slowing the progression of diabetic nephropathy and its cardiovascular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

How to protect the kidney in diabetic patients: with special reference to IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Antihypertensive agents for preventing diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Protein restriction for diabetic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800

inferred from DOI database lookup

7 January 2021

based on heuristic

Pentoxifylline in management of proteinuria in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006800